News

22.10.2018. Updated Common Baltic Package Procedure for the veterinary medicinal products

21.11.2016. Common Baltic Package 

14.06.2016. Amendments to the paid service price list of the Food and Veterinary Service

21.12.2015. Submission of marketing authorisation documentation via CESP 

20.05.2015. Transition to a mandatory usage of eAFs for Veterinary procedures

30.07.2014. On March 28, 2014 the European Commission has adopted the Decision concerning suspension or withdrawal of marketing authorisation for veterinary medicinal products for long-acting formulations for injection containing “barium selenate” for all food producing species

30.07.2014. On February 28, 2014 the European Commission has adopted the Decision concerning the changes in the Summary of Product Characteristics, Labelling and Package Leaflet for veterinary medicinal products containing “enrofloxacin” to be administered via the drinking water to chickens and/or turkeys

23.01.2014. New form is available: Notification of Marketing Status of Veterinary Medicines

01.01.2014. Hereby be informed that due to transition from the lat to the euro from January 1, 2014 came into force new price list

12.02.2013. COMMISSION REGULATION (EU) No 122/2013 of 12 February 2013 amending Regulation (EC) No 1950/2006 establishing, in accordance with Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of equidae [LV]

03.08.2012. COMMISSION REGULATION (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products

26.10.2012. European Medicines Agency on October 26,2012 have published the new template [Version 8, 10/2012]

13.01.2012. „On 13 January 2012 the European Commission has adopted the Decision concerning the marketing authorisations for veterinary medicinal products which contain the active substances "Cefquinome and Ceftiofur"” [LV]